Consultative DXA reporting improves guideline-driven quality of care-implications for increasing DXA reimbursement

Journal of Clinical Densitometry

Volumn 13, Issue 3, 2010, Pages 315-319

  Oppermann, Brian ^a   Ayoub, William ^a   Newman, Eric ^a   Wood, G Craig ^b   Olenginski, Thomas P ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

Bisphosphonate; Dual energy X ray absorptiometry (DXA); High risk osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY;

ABSORPTIOMETRY, PHOTON; AGED; DOCUMENTATION; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; REIMBURSEMENT MECHANISMS; RETROSPECTIVE STUDIES;

EID: 77955512025     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2010.03.001     Document Type: Article

References (18)

1. Consensus Development Conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993, 94:646-650.
2. Kanis J.A. Osteoporosis and its consequences. Osteoporosis 1994, 1-6. Blackwell Science, Cambridge, MA. R. Marcus (Ed.).
3. Cummings S.R., Kelsey J.L., Nevitt M.C., O'Dowd K.J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985, 7:178-208.
4. U.S.Department of Health and Human Services Healthy People 2010: understanding and improving health 2000, U.S. Government Pricing Office, Washington, DC. 2nd ed.
5. Klozbuecher C.M., Ross P.D., Landsman P.B., et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000, 15:721-739.
6. Altkorn D., Vokes T. Treatment of postmenopausal osteoporosis. JAMA 2001, 285:1415-1418.
7. Freedman K.B., Kaplan F.S., Bilker W.B., et al. Treatment of osteoporosis: are physicians missing an opportunity?. J Bone Joint Surg Am 2000, 82:1063-1070.
8. Kamel H.K., Hussain M.S., Tariq S., et al. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000, 109:326-328.
9. Cudhiddy M.T., Gabriel S.E., Crowson C.S., et al. Osteoporosis intervention following distal forearm fractures. A missed opportunity?. Arch Intern Med 2002, 162:421-426.
10. Solomon D.H., Morris C., Chieng H., et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 2005, 80(2):194-202.
11. Blake G.M., Fogelman I. The role of DXA bone mineral density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J 2007, 83:509-517.
12. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994, 4:368-381.
13. Kanis J.A., Borgstrom F., De Lat C., et al. Assessment of fracture risk. Osteoporos Int 2005, 16:581-589.
14. El Maghraoui A., Roux C. DXA scanning in clinical practice. Q J Med 2008, 101:605-617.
15. Binkley N., Krueger D. What should DXA reports contain? Preferences of ordering health care providers. J Clin Densitom 2009, 12(1):5-10.
16. Sunderlin E., Harrington T., Newman E., et al. Mobile DXA physician response to high-risk DXAs: bridging the osteoporosis care gap. Arthritis Rheum 2006, 54(9):S699. [abstract].
17. Sunderlin E., Harrington T., Newman E., et al. Low Z-score reporting in Mobile DXA reporting: it really does matter what we say and recommend. Arthritis Rheum 2006, 54(9):S699. [abstract].
18. Newman E.D., Ayoub W.T., Matzko C.K., Wood C. Glucocorticoid-induced osteoporosis-significant improvement in bisphosphonate use utilizing standardized consultative DXA reporting. Arthritis Rheum 2003, 48:S499. [abstract].